Immunotherapy drug may delay cancer return in head and neck patients
NCT ID NCT02769520
First seen Jan 29, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study tests whether the immunotherapy drug pembrolizumab, given after salvage surgery, can help keep head and neck cancer from coming back in people whose cancer has already returned. About 27 adults with squamous cell carcinoma of the head and neck will receive the drug and be monitored for side effects and how long they stay cancer-free. The goal is to see if this approach improves disease-free survival compared to surgery alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
-
University of California Los Angeles
Torrance, California, 90505, United States
-
University of California San Francisco
San Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.